EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulating Antimicrobial Activity and Structure of the Peptide Esc(1‐21) via Site‐Specific Isopeptide Bond Formation

Bruno Casciaro iD, Daniel Ben Hur iD, Daniela Roversi iD, Carlo Vetrano iD, Edo Kiper iD, Giacomo Cappella iD, Federico Carneri iD, Eeva Tortellini iD, Lorenzo Stella iD, Neta Regev-Rudzki iD, Yechiel Shai iD, Maria Luisa Mangoni iD

Journal of Peptide Science · 2025

DOI: 10.1002/psc.70048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Peptide Science, 2025. Verfasst von Bruno Casciaro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Antimicrobial Peptides, Antimicrobial Cationic Peptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, Sapienza Università di Roma, European Union - NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial peptides (AMPs) represent valid alternatives to conventional antibiotics primarily due to their mechanism of action, which consists of cytoplasmic membrane disruption. However, their clinical application is often limited by cytotoxicity at high concentrations and low intrinsic biostability. To address these limitations, various biochemical approaches have been explored. In recent years, the frog‐skin derived AMP Esc(1‐21) has been extensively characterized for its potent antimicrobial activity, especially against Gram‐negative bacteria, both in vitro and in vivo. In this study, we designed and synthesized novel Esc(1‐21) analogs in which a single isopeptide bond was introduced in place of a conventional peptide bond at specific positions within the sequence. The resulting five analogs were evaluated for their (i) chemical and structural properties, (ii) resistance to proteolytic degradation, (iii) antimicrobial and antibiofilm activities, (iv) hemolytic and cytotoxic effects, and (v) ability to perturb bacterial cytoplasmic membranes. Among these, Esc(1‐21)ε20 showed the most promising features, maintaining antimicrobial and antibiofilm activities comparable to those of the parent peptide while exhibiting lower cytotoxicity towards eukaryotic cells at higher concentrations and greater resistance to enzymatic degradation. These findings highlight Esc(1‐21)ε20 as an attractive lead candidate for the development of new antibiotic therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsAntimicrobial PeptidesAntimicrobial Cationic PeptidesMicrobial Sensitivity TestsAnimalsHumansBiofilmsStructure-Activity RelationshipHemolysisGram-Negative BacteriaAnura

Substanzen

Anti-Bacterial AgentsAntimicrobial PeptidesAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • Laboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, Rome, Italy.
  • Department of Biomolecular Sciences, Faculty of Biochemistry, Weizmann Institute of Science, Rehovot, Israel.
  • Department of Chemical Science and Technologies, University of Rome Tor Vergata, Rome, Italy.
  • Photoinduced Processes and Technologies Doctoral School, Department of Chemistry, Biology and Biotechnology, Perugia University, Perugia, Italy.

ORCID-Profile: Bruno Casciaro, Daniel Ben Hur, Daniela Roversi, Carlo Vetrano, Edo Kiper, Giacomo Cappella, Federico Carneri, Eeva Tortellini, Lorenzo Stella, Neta Regev-Rudzki, Yechiel Shai, Maria Luisa Mangoni

Förderung

  • Ministero dell'Istruzione, dell'Università e della Ricerca
  • Sapienza Università di Roma
  • European Union - NextGenerationEU
  • Dr. Barry Sherman Institute for Medicinal Chemistry
  • BINA - the translational research and innovation unit of the Weizmann Institute
  • Israeli Ministry of Science and Technology
  • Israel Science Foundation (ISF)
  • Rome Technopole

Zitieren

APA

Casciaro, B., Ben Hur, D., Roversi, D., Vetrano, C., Kiper, E., Cappella, G., Carneri, F., Tortellini, E., Stella, L., Regev-Rudzki, N., Shai, Y., & Mangoni, M. L. (2025). Modulating Antimicrobial Activity and Structure of the Peptide Esc(1‐21) via Site‐Specific Isopeptide Bond Formation. Journal of Peptide Science. https://doi.org/10.1002/psc.70048

Vancouver

Casciaro B, Ben Hur D, Roversi D, Vetrano C, Kiper E, Cappella G, et al. Modulating Antimicrobial Activity and Structure of the Peptide Esc(1‐21) via Site‐Specific Isopeptide Bond Formation. Journal of Peptide Science. 2025. doi:10.1002/psc.70048

BibTeX
@article{Casciaro2025,
  author = {Casciaro, Bruno and Ben Hur, Daniel and Roversi, Daniela and Vetrano, Carlo and Kiper, Edo and Cappella, Giacomo and Carneri, Federico and Tortellini, Eeva and Stella, Lorenzo and Regev-Rudzki, Neta and Shai, Yechiel and Mangoni, Maria Luisa},
  title = {Modulating Antimicrobial Activity and Structure of the Peptide Esc(1‐21) via Site‐Specific Isopeptide Bond Formation},
  journal = {Journal of Peptide Science},
  year = {2025},
  doi = {10.1002/psc.70048}
}
Kostenlos starten →